INTERCEPT PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, November 19, 2014, a trademark application was filed for INTERCEPT PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the INTERCEPT PHARMACEUTICALS trademark a serial number of 86458500. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, April 13, 2023. This trademark is owned by Intercept Pharmaceuticals, Inc.. The INTERCEPT PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

House mark for pharmaceutical preparations used to treat chronic liver and intestinal diseases
intercept pharmaceuticals

General Information

Serial Number86458500
Word MarkINTERCEPT PHARMACEUTICALS
Filing DateWednesday, November 19, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, April 13, 2023
Registration Number5055221
Registration DateTuesday, October 4, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2015

Trademark Statements

Goods and ServicesHouse mark for pharmaceutical preparations used to treat chronic liver and intestinal diseases
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 25, 2014
Primary Code005
First Use Anywhere DateTuesday, December 30, 2014
First Use In Commerce DateSunday, May 31, 2015

Trademark Owner History

Party NameIntercept Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameIntercept Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10011
Party NameIntercept Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10011

Trademark Events

Event DateEvent Description
Thursday, April 13, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, April 13, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, April 13, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 4, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, October 4, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, September 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 4, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 29, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 9, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 28, 2016USE AMENDMENT FILED
Thursday, July 28, 2016TEAS STATEMENT OF USE RECEIVED
Thursday, July 28, 2016FAX RECEIVED
Thursday, July 28, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, February 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 23, 2016SOU EXTENSION 1 GRANTED
Friday, January 15, 2016SOU EXTENSION 1 FILED
Saturday, February 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 15, 2016TEAS EXTENSION RECEIVED
Tuesday, July 28, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 29, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 29, 2015ASSIGNED TO LIE
Monday, April 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, March 22, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, March 22, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 7, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 4, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 4, 2015NON-FINAL ACTION E-MAILED
Wednesday, February 4, 2015NON-FINAL ACTION WRITTEN
Thursday, January 29, 2015ASSIGNED TO EXAMINER
Tuesday, November 25, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 22, 2014NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals intercept chronic liver intestinal diseases treat used mark pharmaceutical preparations house